LifeStance Health Group, Inc. LFST

11.84 0.04 0.34% as of 25 Sep
Market cap
$4.5B
P/E
89.0×
Growth Flags show if company had growth for consecutive years
Dec '17 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
— 0.00 0.00 0.00 0.00 0.00 0.00 283.87
P/S ratio
— 14.96 14.96 4.67 1.92 2.75 2.23 1.91
P/FCF ratio
— 0.00 0.00 0.00 0.00 0.00 32.61 24.70
P/Operating CF
— 675.27 675.27 101.78 45.99 172.84 44.84 47.21
P/B ratio
— 7.01 7.01 2.02 1.09 2.03 1.93 1.79
Price to Tangible BV
— 0.00 0.00 77.70 0.00 0.00 0.00 54.35
EV/Sales
— 15.74 15.74 4.69 2.06 2.94 2.33 1.92
EV/EBITDA
— 147.69 147.69 0.00 0.00 0.00 71.20 34.22
EV/Operating CF
— (486.93) (486.93) 332.00 33.50 (183.86) 27.22 18.71
EV/FCF
— (166.98) (166.98) (36.76) (66.82) (54.08) 34.07 24.86
Quick Ratio
— 0.40 0.82 1.92 1.19 1.01 1.25 1.37
Current Ratio
— 0.50 1.00 2.28 1.33 1.11 1.37 1.65
Net Debt/EBITDA
— 3.44 7.24 (0.04) (0.84) (1.89) 3.05 0.22
Debt/Assets
0.00% 28.25% 23.10% 8.17% 10.35% 13.28% 13.21% 12.07%
Debt/Equity
— (0.48) 0.36 0.10 0.15 0.20 0.19 0.17
Asset Turnover
— 1.51 0.41 0.38 0.42 0.49 0.59 0.66
Operating CF/Net income
— (0.29) 0.03 (0.03) (0.24) 0.09 (1.87) 15.12
Capex/Depreciation
— (2.10) (1.19) (1.69) (1.11) (0.49) (0.30) (0.65)
Interest Coverage
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
— (14.16%) (74.88%) (27.05%) (14.07%) (12.64%) (4.00%) 0.65%
ROA
— (41.96%) (33.65%) (19.67%) (10.51%) (8.70%) (2.72%) 0.45%
ROIC
— 0.00% 0.72% (11.51%) (8.03%) (7.25%) (1.26%) 0.98%
Return on Tangible Assets
— 1,142.44% (521.39%) (113.89%) (85.74%) (88.24%) (23.01%) 2.97%
Average Days of Receivables
— 32.00 42.29 41.60 42.83 43.36 38.46 24.53
Research and Development Expense of Revenue
— 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
— 19.32% 19.27% 64.98% 43.98% 38.91% 29.02% 26.83%
Intangible Assets out of Total Assets
0.00 0.82 0.91 0.78 0.71 0.72 0.70 0.67
Share Based Compensation of Revenue
— 0.03% 0.38% 38.87% 21.81% 9.41% 6.09% 5.24%
Graham Net Nets
— (0.08) (0.08) (0.04) (0.26) (0.16) (0.13) (0.10)
Graham Number
— 0.00 0.00 0.00 0.00 0.00 0.00 1.48
Earnings Yield
— (0.71%) (0.71%) (9.65%) (13.12%) (6.46%) (2.11%) 0.35%
Free Cash Flow Yield
— (0.63%) (0.63%) (2.73%) (1.60%) (1.98%) 3.07% 4.05%
Revenue per Share
— 0.57 1.25 2.04 2.42 2.87 3.30 3.69
Operating CF per Share
— 0.05 (0.03) 0.03 0.15 (0.05) 0.28 0.38
Capex per Share
— (0.04) (0.13) (0.29) (0.22) (0.11) (0.06) (0.09)
Free Cash Flow per Share
— 0.01 (0.15) (0.26) (0.07) (0.16) 0.23 0.29
Cash per Share
— 0.01 0.06 0.45 0.31 0.21 0.41 0.64
Shareholders Equity per Share
— (0.45) 3.30 4.72 4.27 3.89 3.81 3.94
Interest Debt per Share
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
— (0.45) 3.30 4.72 4.27 3.89 3.81 3.94
Free Cash Flow
— 2.73 (46.60) (85.07) (26.47) (57.40) 85.69 110.03
Working Capital
— (27.58) 0.36 149.77 57.22 22.86 83.62 164.24
Capital Expenditures
— (14.31) (38.07) (94.49) (79.25) (40.52) (21.57) (36.12)
Net Current Asset Value
— (419.71) (495.61) (115.56) (421.92) (455.31) (359.50) (266.72)
EV/EBIT
— 789.14 789.14 0.00 0.00 0.00 0.00 113.25
Capex to Sales
— 0.07 0.10 0.14 0.09 0.04 0.02 0.03
Net Profit Margin
— (27.72%) (82.53%) (51.53%) (25.08%) (17.64%) (4.59%) 0.68%
Price to Operating Income
— 750.14 750.14 0.00 0.00 0.00 0.00 112.54
Other line items
Depreciation/Fixed assets
— 0.30 0.54 0.37 0.37 0.44 0.44 0.35
Cash ROIC
— 6.44% (4.92%) (7.72%) (7.63%) (11.47%) (3.13%) (0.76%)
Accounts Receivable Turnover
— 5.82 12.10 11.15 9.72 9.33 9.73 12.52
Accounts Payable Turnover
— 25.02 45.55 42.67 47.10 77.94 118.74 144.15
Inventory Turnover
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
— 8.86 10.87 11.08 7.20 3.42 3.12 2.32
Days of Inventory on Hand
— 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
— 36.50 31.17 59.89 88.47 113.14 128.60 113.76
Average Payables
— 6.00 5.67 10.92 13.22 9.67 7.15 6.68
Average Assets
— 140.39 925.26 1,748.42 2,050.49 2,141.92 2,114.13 2,161.12
Average Common Equity
— 416.00 415.74 1,271.43 1,531.88 1,473.83 1,437.61 1,483.65

Fold the line items

Columns are period end dates